CR7650A - MONOCLORHIDRATO DE 2,5-DIONA-3(-1METIL-1H-INDOL-3-iL)-4-[1-(PIRIDIN-2-ILMETIL) PIPERIDIN-4-iL)-1H-INDOL-3-iL)]-1H-PIRROL CRISTALINO - Google Patents
MONOCLORHIDRATO DE 2,5-DIONA-3(-1METIL-1H-INDOL-3-iL)-4-[1-(PIRIDIN-2-ILMETIL) PIPERIDIN-4-iL)-1H-INDOL-3-iL)]-1H-PIRROL CRISTALINOInfo
- Publication number
- CR7650A CR7650A CR7650A CR7650A CR7650A CR 7650 A CR7650 A CR 7650A CR 7650 A CR7650 A CR 7650A CR 7650 A CR7650 A CR 7650A CR 7650 A CR7650 A CR 7650A
- Authority
- CR
- Costa Rica
- Prior art keywords
- indol
- piperidin
- monoclorhydrate
- 1metil
- ilmetil
- Prior art date
Links
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 title abstract 3
- 239000013078 crystal Substances 0.000 title 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- -1 1-methyl-1H-indol-3-yl Chemical group 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 abstract 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 abstract 1
- 125000006514 pyridin-2-ylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se refiere a la sal monoclorhidrato de 2,5 -diona-3-(1-metil-1H-indol-3-il)-4-[1-(piridin-2-ilmetil) piperidin-4-il]-1H indol-3-il]-1H-pirrol cristalino, a una formulacion farmaceutica que contenga dicha sal y a procedimientos de tratamiento del cancer y de inhibicion del crecimiento tumoral utilizando dicha sal.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CR7650A CR7650A (es) | 2005-01-12 | 2005-01-12 | MONOCLORHIDRATO DE 2,5-DIONA-3(-1METIL-1H-INDOL-3-iL)-4-[1-(PIRIDIN-2-ILMETIL) PIPERIDIN-4-iL)-1H-INDOL-3-iL)]-1H-PIRROL CRISTALINO |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CR7650A CR7650A (es) | 2005-01-12 | 2005-01-12 | MONOCLORHIDRATO DE 2,5-DIONA-3(-1METIL-1H-INDOL-3-iL)-4-[1-(PIRIDIN-2-ILMETIL) PIPERIDIN-4-iL)-1H-INDOL-3-iL)]-1H-PIRROL CRISTALINO |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR7650A true CR7650A (es) | 2005-03-11 |
Family
ID=44839270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR7650A CR7650A (es) | 2005-01-12 | 2005-01-12 | MONOCLORHIDRATO DE 2,5-DIONA-3(-1METIL-1H-INDOL-3-iL)-4-[1-(PIRIDIN-2-ILMETIL) PIPERIDIN-4-iL)-1H-INDOL-3-iL)]-1H-PIRROL CRISTALINO |
Country Status (1)
| Country | Link |
|---|---|
| CR (1) | CR7650A (es) |
-
2005
- 2005-01-12 CR CR7650A patent/CR7650A/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2017009I1 (lt) | Brutono tirozinkinazės inhibitoriai | |
| UA95934C2 (ru) | Производные пиридиазинона для лечения опухолей | |
| TW200801008A (en) | Protein kinase inhibitors | |
| ECSP099634A (es) | Derivados de piridazinona útiles como inhibidores de glucano sintasa | |
| SG10201811480WA (en) | Therapeutic compounds and compositions | |
| CL2007002167A1 (es) | Compuestos derivados de indol, antagonistas iap; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de cancer. | |
| SG155163A1 (en) | Pharmacokinetically improved compounds | |
| EP3311818A3 (en) | Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors | |
| DK1654253T3 (da) | Substituerede 3-pyrrolidinindolderivater | |
| CL2011000798A1 (es) | Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular. | |
| ECSP055537A (es) | Monoclorhidrato de 2,5-diona-3-(1-metil-1h-indol-3-il)-4-[1-(piridin-2-ilmetil)piperidin-4-il]-1h-indol-3-il]-1h-pirrol cristalino | |
| TW200722421A (en) | Azole derivatives as inhibitors of lipases and phospholipases | |
| CL2011000806A1 (es) | Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular. | |
| EP2131849A4 (en) | COMPOSITIONS AND METHODS OF DISTRIBUTING AGENTS AGAINST CANCER | |
| SE0300098D0 (sv) | Use of cyclin D1 inhibitors | |
| WO2005039486A3 (en) | Compounds and compositions as protein kinase inhibitors | |
| ATE411981T1 (de) | Tetrahydrocarbazolderivate und deren pharmazeutische verwendung | |
| CR7650A (es) | MONOCLORHIDRATO DE 2,5-DIONA-3(-1METIL-1H-INDOL-3-iL)-4-[1-(PIRIDIN-2-ILMETIL) PIPERIDIN-4-iL)-1H-INDOL-3-iL)]-1H-PIRROL CRISTALINO | |
| EA200702136A1 (ru) | Композиции станнсопорфина и их применение | |
| WO2005082862A3 (en) | Benzimidazolyl derivatives as kinase inhibitors | |
| AR034836A1 (es) | Mono-clorhidrato de 2,5-diona-3-(1-metil-1h-indol-3-il)-4-[1-(piridin-2-ilmetil)piperidin-4-il)-1h-indol-3-il)-1h-pirrol cristalino. | |
| MY138934A (en) | Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride | |
| BR0302183A (pt) | Composto, composição farmacêutica e uso de um composto | |
| TW200731970A (en) | Enhanced efficacy benzisoxazole derivative dosage forms and methods | |
| UA93689C2 (ru) | Фармацевтическая композиция ингибиторов дипептидилпептидазы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |